Evidence map›Paper›PMID 39971959›Full record

ArticleScientific reports2025

Premature ageing of lung alveoli and bone marrow cells from Terc deficient mice with different telomere lengths.

Rosa Guerrero-López, Cristina Manguán-García, Carlos Carrascoso-Rubio, M Luz Lozano, Marta Toldos-Torres, Laura García-Castro, Rebeca Sánchez-Dominguez, Omaira Alberquilla, Isabel Sánchez-Pérez, Maria Molina-Molina and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Rosa Guerrero-López *Instituto de Investigaciones Biomedicas Sols/Morreale, CSIC-UAM. Arturo Duperier, Madrid, 28029, Spain. rosaguerrero@iib.uam.es.
Cristina Manguán-García *Instituto de Investigaciones Biomedicas Sols/Morreale, CSIC-UAM. Arturo Duperier, Madrid, 28029, Spain.
Carlos Carrascoso-RubioHematopoietic Innovative Therapies Division, Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas (CIEMAT)) and Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
M Luz LozanoHematopoietic Innovative Therapies Division, Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas (CIEMAT)) and Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid, Spain.
Marta Toldos-TorresInstituto de Investigaciones Biomedicas Sols/Morreale, CSIC-UAM. Arturo Duperier, Madrid, 28029, Spain.
Laura García-CastroInstituto de Investigaciones Biomedicas Sols/Morreale, CSIC-UAM. Arturo Duperier, Madrid, 28029, Spain.
Rebeca Sánchez-DominguezCentro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain.
Omaira AlberquillaCentro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain.
Isabel Sánchez-PérezInstituto de Investigaciones Biomedicas Sols/Morreale, CSIC-UAM. Arturo Duperier, Madrid, 28029, Spain.
Maria Molina-MolinaILD Unit, Pneumatology Department, University Hospital of Bellvitge, IDIBELL. University of Barcelona, Barcelona, Spain.
Juan A BuerenCentro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain.
Guillermo GuenecheaCentro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain. g.guenetxea@ciemat.es.
Rosario PeronaCentro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), Madrid, 28029, Spain. rperona@iib.uam.es.
Leandro SastreInstituto de Investigaciones Biomedicas Sols/Morreale, CSIC-UAM. Arturo Duperier, Madrid, 28029, Spain. lsastre@iib.uam.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telomeres are terminal protective chromosome structures. Genetic variants in genes coding for proteins required for telomere maintenance cause rare, life-threatening Telomere Biology Disorders (TBDs) such as dyskeratosis congenita, aplastic anemia or pulmonary fibrosis. The more frequently used mice strains have telomeres much longer than the human ones which question their use as in vivo models for TBDs. One mice model with shorter telomeres based on the CAST/EiJ mouse strain carrying a mutation in the Terc gene, coding for the telomerase RNA component, has been studied in comparison with C57BL/6J mice, carrying the same mutation and long telomeres. The possible alterations produced in lungs and the haematopoietic system, frequently affected in TBD patients, were determined at different ages of the mice. Homozygous mutant mice presented a very shortened life span, more notorious in the short-telomeres CAST/EiJ strain. The lungs of mutant mice presented a transitory increase in fibrosis and a significant decrease in the relative amount of the alveolar epithelial type 2 cells from six months of age. This decrease was larger in mutant homozygous animals but was also observed in heterozygous animals. On the contrary the expression of the senescence-related protein P21 increased from six months of age in mutant mice of both strains. The analysis of the haematopoietic system indicated a decrease in the number of megakaryocyte-erythroid progenitors in homozygous mutants and an increase in the clonogenic potential of bone marrow and LSK cells. Bone marrow cells from homozygous mutant animals presented decreasing in vitro expansion capacity. The alterations observed are compatible with precocious ageing of lung alveolar cells and the bone marrow cells that correlate with the alterations observed in TBD patients. The alterations seem to be more related to the genotype of the animals that to the basal telomere length of the strains although they are more pronounced in the short-telomere CAST/EiJ-derived strain than in C57BL/6J animals. Therefore, both animal models, at ages over 6-8 months, could represent valuable and convenient models for the study of TBDs and for the assay of new therapeutic products.

Indexed as

Aging, PrematureBone Marrow CellsPulmonary AlveoliRNATelomeraseTelomereAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMutationTelomere HomeostasisRNATelomerasetelomerase RNAAplastic anemiaCAST/EiJPulmonary fibrosisSenescenceTelomere biology disordersTelomeresTerc

Identifiers

PMID39971959
PMCPMC11840044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.